EuroQoL 5-Dimension 3-Level (EQ-5D-3L)

The EuroQol Group


Basic description

  • Developed in 1990
  • EQ-5D-3L: responses recording three levels of severity
  • EQ-5D-5L: responses recording five levels of severity
  • EQ-5D-Y: Youth version with responses recording three levels of severity

The EuroQol Group

© The Euroqol Group (English source and all translations and all adaptations). EQ-5D™ is a trade mark of the EuroQol Group
To assess health outcome from a wide variety of interventions on a common scale, for purposes of evaluation, allocation and monitoring
Therapeutic area
  • Generic
Therapeutic indication


Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • Dutch for the Netherlands
  • Finnish for Finland
  • Norwegian for Norway
  • Swedish for Sweden
  • English for the UK
Developed simultaneously in all the languages above
181 translation(s)
Bibliographic reference(s) of the original questionnaire

Rabin R, de Charro F.  EQ-5D: a measure of health status from the EuroQol Group.  Ann Med. 2001 Jul;33 (5): 337-43 (Full text article)

De Charro F, Rabin R. EQ-5D from the EuroQol group: an update. QOL Newsletter, 2000; 25 

Kind P, Dolan P, Gudex C et al. Variations in population health status: results from a United kingdom national questionnaire survey. BMJ 1998;316 (7133): 736-741 (Full text article)

Brooks R. EuroQol: the current state of play. Health Policy 1996; 37 (1): 53-72 (PubMed abstract)

EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208 (PubMed Abstract)

Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013 Sep;22(7):1717-27 (Full text article)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us